WENTWORTH KORY JAMES (Chief Financial Officer) reported 1 transaction at ENTRADA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/3/2026ACC: 0001725663-26-000007
Officer· Chief Financial Officer
Since Oct 2021
-1.73K
Net shares
Net seller
$12.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.73K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.73K
Price / share
$7.14
Trade value
$12.38K
% of position
1.5%
9/2/2026
119.01K→117.28K
Total
Net shares
−1.73K
Net value
-$12.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | F · Tax Withholding | −1.73K | $7.14 | $12.38K | 1.5% | 119.01K | 117.28K |
| Total | −1.73K | -$12.38K | ||||||
Derivative Transactions0
No derivative transactions reported